Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Kucukoglu, Mehmet; HANTA, İSMAİL; AKDENİZ, BAHRİ; Gullulu, Sumeyye; Atahan, Ersan; SAYIN, TAMER; Okumus, Gulfer; ÖNEN, ZEYNEP; Yokusoglu, Mehmet; Baygul, Arzu

doi:10.5152/anatoljcardiol.2021.03009

Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

Kucukoglu M. S., HANTA İ., AKDENİZ B., Gullulu S., Atahan E., SAYIN T., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.25, sa.10, ss.721-732, 2021 (SCI-Expanded, Scopus, TRDizin)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 25 Sayı: 10
Basım Tarihi: 2021
Doi Numarası: 10.5152/anatoljcardiol.2021.03009
Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.721-732
Anahtar Kelimeler: pulmonary arterial hypertension, iloprost, treatment outcome, safety, survival, COMBINATION THERAPY, ORAL SILDENAFIL, TARGETED DRUGS, NITRIC-OXIDE, PROSTACYCLIN, METAANALYSIS, INSIGHTS
Ankara Üniversitesi Adresli: Evet

Özet

Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost treatment in the daily practice for the management of pulmonary arterial hypertension (PAH).